Boostrix, Adacel Tdap Boosters Are Effective, FDA Advisory Committee Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory panel members urge postmarket monitoring for GSK and Sanofi Pasteur boosters in patients who received full series of acellular pertussis vaccines as children, given that the studies were conducted in patients who received whole-cell vaccines. Committee endorses “effectiveness,” but offers no opinion on “efficacy.”